Johnson & Johnson on Track for Record High Close — Data Talk
Johnson & Johnson (JNJ) is currently at $253.69, up $8.81 or 3.6%
--Would be new all-time closing high (Based on available data back to Jan. 21, 1972)
--Would be the first record close since March 2, 2026, when it closed at $248.56
--On pace for largest percent increase since July 16, 2025, when it rose 6.19%
--Currently up five consecutive days; up 11.08% over this period
--Longest winning streak since Feb. 6, 2026, when it rose for five straight trading days
--Best five day stretch since the five days ending April 8, 2020, when it rose 11.22%
--Up 11.08% this week; best weekly performance since the week ending Oct. 17, 2008, when it rose 12.18%
--Up 12.59% month-to-date; on pace for best month since April 2020, when it rose 14.42%
--Up 22.58% year-to-date
--Up 66.45% from 52 weeks ago (June 27, 2025), when it closed at $152.41
--Would be a new 52-week closing high
--Up 66.45% from its 52-week closing low of $152.41 on June 27, 2025
--Traded as high as $254.00; new all-time intraday high (Based on available data back to Jan. 21, 1972)
--Up 3.72% at today's intraday high; largest intraday percent increase since July 16, 2025, when it rose as much as 7.06%
--Fourth best performer in the DJIA today
--Contributed 54.24 points to the DJIA so far today
All data as of 11:30:41 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 26, 2026 11:50 ET (15:50 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
3 Stocks to Invest In With More Room to Run
